|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: I STAT CORPORATION /DE/, 10-Q, 2000-11-13 |
Next: BIOCRYST PHARMACEUTICALS INC, 10-Q, 2000-11-13 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 22,129
<SECURITIES> 0
<RECEIVABLES> 4,398
<ALLOWANCES> (32)
<INVENTORY> 14,717
<CURRENT-ASSETS> 42,439
<PP&E> 43,641
<DEPRECIATION> (26,607)
<TOTAL-ASSETS> 61,417
<CURRENT-LIABILITIES> 16,638
<BONDS> 0
0
0
<COMMON> 2,755
<OTHER-SE> 36,901
<TOTAL-LIABILITY-AND-EQUITY> 61,417
<SALES> 39,416
<TOTAL-REVENUES> 39,416
<CGS> 30,247
<TOTAL-COSTS> 30,247
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (8,274)
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (8,274)
<EPS-BASIC> (.46)
<EPS-DILUTED> (.46)
</TABLE>
|
|